Article
Whole genome sequencing with AVITI and NovaSeq X Plus reveals comparable performance with contextual biases
2025-10-10
Abstract excerpt
<h4>ABSTRACT</h4> Element Biosciences’ avidity sequencing has emerged as a competing technology to Illumina’s short read sequencing platform. Prior benchmarks of avidity sequencing have not included the latest Illumina NovaSeq X/X Plus instruments with XLEAP chemistry. Here, we have run PCR-free whole genome sequencing on four human tumor cell lines using both Illumina NovaSeq X Plus and Element AVITI instruments...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f8ce03fa-9788-5785-aa1a-8b8aed8391a6
- DOI
- 10.1101/2025.10.10.681584
